During the past 12 months, West Pharmaceutical Services's average EPS without NRIGrowth Rate was -5.80% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 19.30% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 28.60% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 21.10% per year.
During the past 13 years, West Pharmaceutical Services's highest 3-Year average EPS without NRI Growth Rate was 47.70% per year. The lowest was -22.60% per year. And the median was 11.20% per year.
West Pharmaceutical Services Earnings per Share (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
West Pharmaceutical Services Earnings per Share (Diluted) Chart
Competitive Comparison of West Pharmaceutical Services's Earnings per Share (Diluted)
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's PE Ratio distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's PE Ratio falls into.
West Pharmaceutical Services Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
West Pharmaceutical Services's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
West Pharmaceutical Services (NYSE:WST) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
West Pharmaceutical Services Earnings per Share (Diluted) Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services (West Pharmaceutical Services) Business Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WST has been successfully added to your 